ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →

Thursday, 12 November 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Evonile Pharma Ltd

NSE: NOVARTIND · BSE: 500672 · Pharmaceuticals & Biotechnology · 48 announcements

Evonile Pharma Ltd news stories on ALFA NewsRead the news →

Share price: ₹1,562.55
Market cap: ₹5,064 Cr
Revenue (annual): ₹354.3 Cr
Net profit (annual): ₹93.18 Cr
P/E (TTM): -1269.1×Sector 43.8×
Promoter holding: 70.68%+0.00% QoQ
FII holding: 1.21%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 4 Other Announcement 3 Annual General Meeting 3 Fund Raise 2 Board Meeting Date 2 Results Update 1 Partnership 1 Management Change 1 Financial Results 1 Credit Rating 1 Capital Structure Change 1 Business Update 1 Board Meeting Outcome 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

3 Nov 2026 20:01 IST BSE

Evonile Pharma Results Update

Evonile Pharma reported Q2 FY27 revenue of ₹56.1 crore and an EBITDA loss of ₹31.8 crore. H1 FY27 profit after tax was a loss of ₹45.3 crore.

Open announcement → Read the filing ↗

Evonile Pharma Ltd by type